These results suggest that, while TP53 mutations are commonly observed, other genetic changes in genes such as CDH1, KMT2D, APC, ATM, MSI‐H, and TMB differ between early‐ and late‐onset cases of GC. The gene discussed is TP53; the disease is gastric cancer.